MAGNESIUM CHLORIDE DIETARY SUPPLEMENT- magnesium chloride tablet, delayed release 
LEADING PHARMA

----------

Statement of Identity

Magnesium Chloride 598mg E/C White Tablets.

Warning

Keep out of the reach of children.

Dosage and Administration:

Serving Size: two tablets.

As a dietary supplement, take 2 tablets daily or as directed by your physician. Tablets should be swallowed whole.

Storage

Store in a dry location at 59° to 77° F (15°-25° C).

leading label

MAGNESIUM CHLORIDE  DIETARY SUPPLEMENT
magnesium chloride tablet, delayed release
Product Information
Product TypeDIETARY SUPPLEMENTItem Code (Source)NHRIC:69315-209
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MAGNESIUM CHLORIDE (UNII: 02F3473H9O) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM CATION598 mg
Inactive Ingredients
Ingredient NameStrength
CALCIUM CARBONATE (UNII: H0G9379FGK)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
TALC (UNII: 7SEV7J4R1U)  
TRIACETIN (UNII: XHX3C3X673)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
POVIDONE (UNII: FZ989GH94E)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
ACACIA (UNII: 5C5403N26O)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
SHELLAC (UNII: 46N107B71O)  
FD&C BLUE NO. 2 (UNII: L06K8R7DQK)  
MINERAL OIL (UNII: T5L8T28FGP)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NHRIC:69315-209-0660 in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
DIETARY SUPPLEMENT03/24/201601/10/2024
Supplement Facts
Serving Size : Serving per Container :
Amount Per Serving% Daily Value
color
scoring1
shape
size (solid drugs)14 mm
Labeler - LEADING PHARMA (079575060)
Registrant - TIME CAP LABORATORIES,INC (037052099)
Establishment
NameAddressID/FEIBusiness Operations
TIME CAP LABORATORIES,INC037052099analysis(69315-209) , manufacture(69315-209)

Revised: 1/2024
Document Id: cda67767-950f-4fe7-91f7-371acc1a472c
Set id: 40c18435-ae27-4740-b69e-6bcd1aec3212
Version: 4
Effective Time: 20240113
 
LEADING PHARMA